-
-

 
-
Nov 1 2022
Recent article published in Molecular Oncology with MedRod® implants i...

-


PRICE QUOTE AND TECHNICAL INQUIRIES

Request Information


FOLLOW US

17beta estradiol

For mice and rats in metabolic and breast cancer xenograft, PDX and syngeneic studies

17β-estradiol (E2) implants for preclinical in vivo studies.
Exposure time: At least 100 days, specific implants up to several years
Dose range: 0.25 µg – 15 µg/day

-
About Us
 
-
 Management
-
 History
-
Implant Technology
 
-
 E1
-
 E2
-
 DHT
-
 P4
-
 TE
-
 LTZ
-
Drug Delivery Solutions
 
-
 Feasibility study of novel compound
-
Services
 
References
 
-
 MedRod brochure
-
Contact Us
 
Benefits of MedRod®
 
138415  | Copyright © 2023 PreclinApps Ltd   
Web dev. Webbinen.net